TCM
Tanaka Capital Management Portfolio holdings
AUM
$42M
This Quarter Return
+6.61%
1 Year Return
+55.15%
3 Year Return
+143.07%
5 Year Return
+988.77%
10 Year Return
+1,815.39%
AUM
$45.4M
AUM Growth
+$45.4M
(+6.1%)
Cap. Flow
-$943K
Cap. Flow
% of AUM
-2.08%
Top 10 Holdings %
Top 10 Hldgs %
60.24%
Holding
58
New
4
Increased
4
Reduced
27
Closed
3
Top Buys
| 1 |
NTRP
Neurotrope, Inc. Common
NTRP
|
$1.75M |
| 2 |
AMRS
Amyris Inc.
AMRS
|
$1.14M |
| 3 |
Inovio Pharmaceuticals
INO
|
$642K |
| 4 |
NexGen Energy
NXE
|
$95.5K |
| 5 |
Meta Platforms (Facebook)
META
|
$31.2K |
Top Sells
| 1 |
ATTU
Attunity Ltd
ATTU
|
$1.06M |
| 2 |
Tesla
TSLA
|
$732K |
| 3 |
PARAA
Paramount Global Class A
PARAA
|
$661K |
| 4 |
Catalyst Pharmaceutical
CPRX
|
$599K |
| 5 |
Honeywell
HON
|
$178K |
Sector Composition
| 1 | Technology | 23.89% |
| 2 | Healthcare | 23.89% |
| 3 | Industrials | 9.92% |
| 4 | Energy | 9.24% |
| 5 | Communication Services | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NexGen Energy
NXE
$4.5B
| $4.17M | 9.19% | 1,774,609 +40,637 | +2% | +$95.5K |
|
2
Tower Semiconductor
TSEM
$6.58B
| $4.05M | 8.93% | 175,733 -2,830 | -2% | -$65.2K |
|
3
Ionis Pharmaceuticals
IONS
$6.79B
| $3.35M | 7.39% | 83,399 -1,554 | -2% | -$62.5K |
|
|
PARAA
4
DELISTED
Paramount Global Class A
PARAA
| $3.13M | 6.9% | 45,091 -9,525 | -17% | -$661K |
|
5
Apple
AAPL
$3.45T
| $3.07M | 6.76% | 21,358 -828 | -4% | -$119K |
|
6
Alaska Air
ALK
$7.24B
| $1.84M | 4.07% | 19,998 -947 | -5% | -$87.3K |
|
|
NTRP
7
DELISTED
Neurotrope, Inc. Common
NTRP
| $1.75M | 3.85% | +91,465 | New | +$1.75M |
|
|
CELG
8
DELISTED
Celgene Corp
CELG
| $1.74M | 3.84% | 13,982 -235 | -2% | -$29.2K |
|
|
RTEC
9
DELISTED
Rudolph Technologies Inc
RTEC
| $1.59M | 3.5% | 70,827 -3,612 | -5% | -$80.9K |
|
|
10
Tesla
TSLA
$1.08T
| $1.31M | 2.89% | 4,711 -2,631 | -36% | -$732K |
|
11
Aflac
AFL
$57.2B
| $1.2M | 2.64% | 16,523 -413 | -2% | -$29.9K |
|
|
AMRS
12
DELISTED
Amyris Inc.
AMRS
| $1.14M | 2.52% | +2,156,762 | New | +$1.14M |
|
|
ADXS
13
DELISTED
Advaxis, Inc.
ADXS
| $1.12M | 2.48% | 137,483 -1,445 | -1% | -$11.8K |
|
14
Qualcomm
QCOM
$173B
| $998K | 2.2% | 17,412 -439 | -2% | -$25.2K |
|
15
JetBlue
JBLU
$1.95B
| $950K | 2.09% | 46,072 -1,709 | -4% | -$35.2K |
|
16
Corcept Therapeutics
CORT
$7.35B
| $939K | 2.07% | 85,705 -1,610 | -2% | -$17.6K |
|
17
GE Aerospace
GE
$292B
| $909K | 2% | 30,518 -1,122 | -4% | -$33.4K |
|
18
Onto Innovation
ONTO
$5.19B
| $863K | 1.9% | 28,319 -252 | -0.9% | -$7.68K |
|
|
19
Honeywell
HON
$139B
| $782K | 1.72% | 6,266 -1,429 | -19% | -$178K |
|
20
Helen of Troy
HELE
$564M
| $717K | 1.58% | 7,608 -301 | -4% | -$28.4K |
|
21
Stifel
SF
$11.8B
| $684K | 1.51% | 13,625 -135 | -1% | -$6.78K |
|
|
22
Inovio Pharmaceuticals
INO
$126M
| $642K | 1.42% | +96,925 | New | +$642K |
|
23
Philip Morris
PM
$260B
| $626K | 1.38% | 5,548 -60 | -1% | -$6.77K |
|
24
Amgen
AMGN
$155B
| $551K | 1.21% | 3,358 -381 | -10% | -$62.5K |
|
|
25
Catalyst Pharmaceutical
CPRX
$2.52B
| $416K | 0.92% | 241,753 -348,130 | -59% | -$599K |
|